ATE800T1 - PHTHALAZINES ACTIVE CARDIAC STIMULANTS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. - Google Patents
PHTHALAZINES ACTIVE CARDIAC STIMULANTS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.Info
- Publication number
- ATE800T1 ATE800T1 AT80300909T AT80300909T ATE800T1 AT E800 T1 ATE800 T1 AT E800T1 AT 80300909 T AT80300909 T AT 80300909T AT 80300909 T AT80300909 T AT 80300909T AT E800 T1 ATE800 T1 AT E800T1
- Authority
- AT
- Austria
- Prior art keywords
- phthalazines
- preparation
- pharmaceutical compositions
- compositions containing
- active cardiac
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
- C07D211/28—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/42—Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7910843 | 1979-03-28 | ||
| EP80300909A EP0017411B1 (en) | 1979-03-28 | 1980-03-24 | Phthalazine cardiac stimulants, processes for preparing them, and pharmaceutical compositions containing them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE800T1 true ATE800T1 (en) | 1982-04-15 |
Family
ID=10504188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT80300909T ATE800T1 (en) | 1979-03-28 | 1980-03-24 | PHTHALAZINES ACTIVE CARDIAC STIMULANTS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0017411B1 (en) |
| JP (1) | JPS55130973A (en) |
| AR (2) | AR224518A1 (en) |
| AT (1) | ATE800T1 (en) |
| AU (1) | AU518701B2 (en) |
| DE (1) | DE3060253D1 (en) |
| DK (1) | DK129380A (en) |
| ES (2) | ES489947A0 (en) |
| FI (1) | FI800938A (en) |
| GR (1) | GR67739B (en) |
| IL (1) | IL59619A0 (en) |
| PH (1) | PH15981A (en) |
| PT (1) | PT71025A (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2744451B1 (en) * | 1996-02-01 | 1998-04-24 | Pf Medicament | NOVEL IMIDAZOLIDINONES, PYRIMIDINONES, AND 1,3-DIAZEPIN-2 -ONES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATIONS |
| AU3784997A (en) * | 1996-08-09 | 1998-03-06 | Eisai Co. Ltd. | Benzopiperidine derivatives |
| WO2012006276A1 (en) * | 2010-07-06 | 2012-01-12 | North Carolina State University | Inhibition of bacterial biofilms with aryl carbamates |
| US9125408B2 (en) | 2010-09-01 | 2015-09-08 | North Carolina State University | Use of aryl carbamates in agriculture and other plant-related areas |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN148482B (en) * | 1977-06-03 | 1981-03-07 | Pfizer | |
| GB2008104B (en) * | 1977-11-03 | 1982-03-10 | Pfizer Ltd | Therapeutic agents |
| GB2007654B (en) * | 1977-11-03 | 1982-06-16 | Pfizer Ltd | Therapeutic agents |
-
1980
- 1980-03-14 IL IL59619A patent/IL59619A0/en unknown
- 1980-03-22 GR GR61520A patent/GR67739B/el unknown
- 1980-03-24 DE DE8080300909T patent/DE3060253D1/en not_active Expired
- 1980-03-24 AT AT80300909T patent/ATE800T1/en not_active IP Right Cessation
- 1980-03-24 EP EP80300909A patent/EP0017411B1/en not_active Expired
- 1980-03-25 PH PH23810A patent/PH15981A/en unknown
- 1980-03-26 DK DK129380A patent/DK129380A/en not_active IP Right Cessation
- 1980-03-26 ES ES489947A patent/ES489947A0/en active Granted
- 1980-03-26 FI FI800938A patent/FI800938A/en not_active Application Discontinuation
- 1980-03-27 JP JP3963480A patent/JPS55130973A/en active Granted
- 1980-03-27 PT PT71025A patent/PT71025A/en unknown
- 1980-03-27 AU AU56917/80A patent/AU518701B2/en not_active Ceased
- 1980-03-28 AR AR280444A patent/AR224518A1/en active
- 1980-11-26 ES ES497172A patent/ES497172A0/en active Granted
-
1981
- 1981-06-02 AR AR285555A patent/AR223434A1/en active
Also Published As
| Publication number | Publication date |
|---|---|
| FI800938A (en) | 1980-09-29 |
| DK129380A (en) | 1980-09-29 |
| AR224518A1 (en) | 1981-12-15 |
| ES8200103A1 (en) | 1981-10-16 |
| JPS5716111B2 (en) | 1982-04-02 |
| ES8104273A1 (en) | 1981-04-16 |
| AR223434A1 (en) | 1981-08-14 |
| AU5691780A (en) | 1980-10-02 |
| JPS55130973A (en) | 1980-10-11 |
| GR67739B (en) | 1981-09-16 |
| EP0017411B1 (en) | 1982-03-31 |
| ES497172A0 (en) | 1981-10-16 |
| PT71025A (en) | 1980-04-01 |
| ES489947A0 (en) | 1981-04-16 |
| AU518701B2 (en) | 1981-10-15 |
| DE3060253D1 (en) | 1982-05-06 |
| IL59619A0 (en) | 1980-06-30 |
| EP0017411A1 (en) | 1980-10-15 |
| PH15981A (en) | 1983-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE6934T1 (en) | SULFONYL UREAS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS. | |
| ATE17725T1 (en) | ANTI-INFLAMMATORY ACTIVE 5-SUBSTITUTE-2,3DIARYL-THIOPHENE, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| ATE6859T1 (en) | SUBSTITUTED 3-AMINO-SYDNONIMINE, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM. | |
| ATE8892T1 (en) | SUBSTITUTED AZABICYCLOOCTANECARBOXYLIC ACID, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| ATE4707T1 (en) | PYRIDYL AND IMIDAZOPYRIDYLOXYPROPANOLAMINES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| ATE27451T1 (en) | ACYL-QUINOLINONE DERIVATIVES, PROCESS FOR THEIR MANUFACTURE, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND THEIR USE. | |
| PT68492A (en) | FLUORO-SUBSTITUTED PHENOXYBENZYLOXYCARBONYL DERIVATIVES PROCESS FOR THEIR PREPARATION AND THEIR USE AS INSECTICIDES AND ACARICIDES | |
| ATE10634T1 (en) | PYRAZOLOINDAZOLE DERIVATIVES, PROCESS FOR THEIR MANUFACTURE AND PHARMACEUTICAL PREPARATION CONTAINING THEM. | |
| ATE10094T1 (en) | 3,4-BIS-SUBSTITUTED 1,2,5-OXADIAZOLE-2-OXIDES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM. | |
| PT71967A (en) | HOMOSERIN DERIVATIVES PROCESS FOR THEIR PREPARATION AND THEIR USE AS MICROBICIDES | |
| ATE800T1 (en) | PHTHALAZINES ACTIVE CARDIAC STIMULANTS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| ATE3422T1 (en) | TETRAHYDROCHINOLINE DERIVATIVES, PROCESS FOR THEIR MANUFACTURE, THEIR USE AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM. | |
| ATE3425T1 (en) | HYPOGLYKAEMIC GUANYLAMIDINS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| ATE3976T1 (en) | SUBSTITUTED 3-(1-PYRROLIDINYL)-5-SULFAMOYLBENZOES[URE DERIVATIVES, PROCESS FOR THEIR MANUFACTURE, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND PROCESS FOR THEIR MANUFACTURE. | |
| ATE2673T1 (en) | PHENOTHIAZIN DERIVATIVES, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND PROCESSES FOR THEIR MANUFACTURE. | |
| ATE12116T1 (en) | 7-ACYLAMINO-3-SUBSTITUTED CEPHALASPORAN ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| ATE6653T1 (en) | CLAVULAN ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| ATE722T1 (en) | OCTAHYDRO-1H-BENZO(4,5)FU RO(3,2-E)ISOCHINOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| ATE1014T1 (en) | SUBSTITUTED-19-NOR-PREG N-4-EN-3,20-DIONE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| ATE876T1 (en) | ANTI-INFLAMMATORY 4,5-DIARYL-2-NITROIMIDAZOLE, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEM. | |
| ATE11288T1 (en) | NICOTINE-1-OXIDE THIOALKYLAMIDE, ITS SALTS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS. | |
| ATE587T1 (en) | INDOLALKYLAMINE, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND PROCESSES FOR THEIR MANUFACTURE. | |
| ATE21515T1 (en) | 7-N-HETEROCYCLYL CEPHALOSPORIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEM. | |
| ATE6503T1 (en) | CARBOXYALKYL DIPEPTIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEM. | |
| ATE6515T1 (en) | TETRAHYDROISOCHINOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |